Skin care brand to focus on existing US customer relationships to challenge in competitive market
As part of its new plan, promotional efforts will be highly targeted to support existing internal sales efforts, current client sales efforts, and to build brand awareness and grow market share for the Dermacyte brand.
"We have gathered a substantial amount of data in the last few months and have determined that the shotgun approach to promotion is much too costly and challenging in this highly competitive anti-aging skin care market," said Michael Jebsen, president and CFO.
Capitalize on strong relationships
The new strategy is part of an overall program designed to capitalize on the relationships the company has built over the last year in the top markets that have adopted the company’s Dermacyte cosmetic products into their practices.
"We learned that there is a committed group of customers who love our product and are willing to do all they can to help us succeed so that they are able to continue to purchase our products for themselves and their clients,” said Jebsen.
The new plan was implemented following the termination of OB’s agreements covering distribution of Dermacyte in Europe and Mexico which was reported on a Form 8-K filed by the company with the Securities and Exchange Commission.
“Over the next few months, we plan to engage local, grassroots efforts to advertise and promote our brand, build credibility and engage our customers in spreading the value and benefits of Dermacyte on our behalf through their own experiences. These efforts will be supplemented by continued online sales and promotions," said Jebsen.
New strategy, new packaging
In addition, the company, which develops medical and cosmetic products that efficiently deliver oxygen to tissues in the body, plans to introduce new packaging of its flagship products, Dermacyte Concentrate and Dermacyte Oxygenating Eye Complex.
The new packaging will incorporate feedback generated from customers regarding product volume, pricing and dispensing.
